ReachMD

Be part of the knowledge.™

Oncology - Hematology

66

LikeLikedUnlike

Episodes 1-15 of 18

- Jennifer Caudle, DO
  Peer
- Kristin Higgins, MD
  Peer
1
Medical Industry Feature
Best Practices for Curative-Intent Concurrent Chemoradiation Therapy in Unres...
- Jennifer Caudle, DO
  Peer
- Alexander Whitley, MD
  Peer
- Alejandro Calvo, MD
  Peer
- Kim Rohan, MS APN, AOCN
  Peer
2
Medical Industry Feature
Multidisciplinary Perspectives on Managing Patients with Unresectable Stage I...
- Michael D. Tarantino, MD
  Peer
1
Medical Industry Feature
Inhibitor Insights: Stanley’s Journey, a Case Study in Acquired Hemophilia A
- John J. Russell, MD
  Peer
- Jeanny Aragon-Ching, MD
  Peer
4
Medical Industry Feature
Need-to-Know Data for a Treatment Option in Advanced RCC
- Michael D. Tarantino, MD
  Peer
1
Medical Industry Feature
Inhibitor Insights: Caroline's Journey, a Case Study in Acquired Hemophilia A
- Michael D. Tarantino, MD
  Peer
0
Medical Industry Feature
Congenital vs. Acquired Hemophilia: Different Disorders, Different Approaches
- Jennifer Caudle, DO
  Peer
- Timothy Kruser, MD
  Peer
0
Navigating Unresectable Stage III NSCLC: Radiation Oncologist Perspectives
Updates From the PACIFIC Study & Its Impact on the Unresectable Stage III NSC...
- Jenn Simmons, MD
  Peer
- Clark C. Chen, MD, PhD
  Peer
- David Piccioni, MD, PHD
  Peer
- Christina I. Tsien, MD
  Peer
3
Medical Industry Feature
A Look at Current & Potential Therapies for High Grade Glioma
- Jennifer Caudle, DO
  Peer
- Daniel J. DeAngelo, MD, PhD
  Peer
4
Medical Industry Feature
Minimal Residual Disease & the Future of B-Cell ALL Treatment
- Matt Birnholz, MD
  Peer
- Ajai Chari, MD
  Peer
5
Medical Industry Feature
The BiTE® Immuno-Oncology Platform & Emerging Targets in Oncology
- Jeffrey V. Matous, MD
  Peer
1
$Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy$ $Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy$
Medical Industry Feature
Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy
- Joshua Richter, MD
  Peer
1
$Overall Survival Data in Patients with Relapsed/Refractory Multiple Myeloma$ $Overall Survival Data in Patients with Relapsed/Refractory Multiple Myeloma$
Medical Industry Feature
Overall Survival Data in Patients with Relapsed/Refractory Multiple Myeloma
- Sophie Balzora, MD, FACG
  Peer
- Jonathan Cohen, MD
  Peer
5
Medical Industry Feature
Measuring Bowel Prep Efficacy: The Role of the Quality Assessment Scale
- Sophie Balzora, MD, FACG
  Peer
- Lawrence Hookey, MD
  Peer
6
Medical Industry Feature
Efficacy of a Next Generation Low Volume Bowel Prep
- Sophie Balzora, MD, FACG
  Peer
- Carol A. Burke, MD, FACG, FASGE, AGAF, FACP
  Peer
6
Medical Industry Feature
Optimizing the Effectiveness of Colonoscopy for Colorectal Cancer Prevention:...

Loading...

Programs 1/21/20

Segment Chapters

Playlist:

Recommended